Study reveals HPV vaccine impact on anal cancer
In a new study, researchers found evidence that HPV vaccination is reducing the incidence of anal cancer among young adults in the US. Researchers at the University of Texas Medical Branch analyzed data from the US Cancer Statistics database from 2001 to 2018 to examine anal cancer incidences among different age groups and determine the potential impact of HPV vaccination. They found that cancer incidence among young adults 20 to 44 years of age began to rapidly and significantly decrease within...










